This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SAP And BC Centre For Excellence In HIV /AIDS Pioneer New Technology, Redefine Treatment





VANCOUVER, British Columbia, Feb. 25, 2014 /PRNewswire/ -- The British Columbia Centre for Excellence in HIV /AIDS at St. Paul's Hospital is pioneering new technology from PHEMI Health Systems and SAP AG (NYSE: SAP) to accelerate the treatment and improve the outcome for patients diagnosed with HIV/AIDS. The Centre intends to roll out powerful Big Data technology in a pilot project to deliver personalized medicine based on the genetic signature of the virus that infects each patient.

(Logo: http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO)

"We're changing the face of treatment for HIV and AIDS," said Dr. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS. "This technology will be invaluable to the lives of our patients. We will be able to quickly treat patients by delivering personalized medicine based on their unique strain of the virus. This will help us save time and money while also significantly decreasing the number of new HIV and AIDS cases. For the first time, we will have access to vast amounts of information and get answers immediately thanks to technology from PHEMI and SAP."

The Center for Excellence aims to implement PHEMI Central's healthcare data warehouse and the SAP HANA® platform. PHEMI Central shall be used to store, archive and govern the research and clinical information in a healthcare-specific data warehouse that is embedded with  'Privacy by Design' capabilities. The solutions from PHEMI and SAP are envisioned to be used together, delivering advanced, personalized and private medicine information.

"Over 70 percent of healthcare information is unstructured and difficult to mine for relevant insight using traditional methods," said Dr. Paul Terry, CEO of PHEMI Health Systems. "What we intend to offer healthcare professionals, essentially, is the ability to turn physician letters and lab results into searchable information, thereby helping to unlock vast amounts of new information for clinicians, analysts and researchers."

"Our cooperation with PHEMI and the work we do with the Centre for Excellence is a great proof point highlighting that forward-thinking Canadian companies, taking bold actions, can lead the world in their industries," said Bob Elliott, managing director, SAP Canada. "Doctors and researchers are envisioned to have a much faster way of treating patients. Working together, we plan on lowering healthcare costs by speeding up treatment plans, improving patient care and addressing chronic disease as a whole."

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada's largest HIV/AIDS research, treatment and education facility and is internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases.

For more information, visit the SAP Newsroom.

About PHEMI:PHEMI Health Systems is a process automation and Big Data platform company that unlocks patient data to improve clinic productivity, patient outcomes, and medical research. The PHEMI team architected PHEMI Clinical and PHEMI Central from the ground up specifically for healthcare to fully incorporate the 7 foundational principles of Privacy by Design as applied to Big Data. For more information, please visit http://www.phemi.com.

About SAPAs market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 253,500 customers to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs